Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Q'Apel Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Q'Apel Medical

Q'Apel Medical

Series B

Q'Apel Medical, a California-based company, designs innovative neurovascular intervention devices since 2016.

HQ
Fremont, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded in 2016 and headquartered in Fremont, California, Q'Apel Medical specializes in designing advanced access device technology for neurovascular interventions. The company aims to address unmet clinical needs through its innovative products, which include neurological catheters designed to navigate the complex twists and turns of the brain's neurovasculature. Q'Apel Medical focuses on empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Notable affiliated individuals and investors have supported Q'Apel Medical's mission, contributing to its rapid growth and success. The company has achieved significant milestones in the medical device industry, earning recognition for its cutting-edge technology and impactful solutions. Q'Apel Medical continues to make a substantial impact on neurovascular healthcare, improving patient outcomes and advancing the field of medical device innovation.

Q'Apel Medical - Similar Companies

Neurvana Medical logo

Neurvana Medical

Conformal Medical logo

Conformal Medical

Mivi Neuroscience logo

Mivi Neuroscience

mivineuro.com

Penumbra logo

Penumbra

penumbrainc.com

Apex Neuro logo

Apex Neuro

Galaxy Therapeutics logo

Galaxy Therapeutics

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Artio Medical logo

Artio Medical

Scientia Vascular logo

Scientia Vascular

eLum Technologies logo

eLum Technologies

Micro Medical Solutions logo

Micro Medical Solutions

Palmera Medical logo

Palmera Medical

IntuiTap Medical logo

IntuiTap Medical

nQ Medical logo

nQ Medical

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Q'Apel Medical - Quick Facts

Who are Q'Apel Medical's competitors?

Companies similar to Q'Apel Medical include Neurvana Medical, Conformal Medical, Mivi Neuroscience and Penumbra.

When was Q'Apel Medical founded?

Q'Apel Medical was founded in 2016.

Where is Q'Apel Medical's headquarters located?

Q'Apel Medical's headquarters is located in Fremont, CA, US.

When was Q'Apel Medical's last funding round?

Q'Apel Medical's most recent funding round was for $29.9M (USD) in April 2022.

How much has Q'Apel Medical raised to-date?

As of Apr 4, 2022, Q'Apel Medical has raised a total of $51.9M (USD).

How many employees does Q'Apel Medical have?

Q'Apel Medical has 85 employees as of Feb 5, 2024.

Q'Apel Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified